piracetam has been researched along with Depression, Endogenous in 11 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with cognitive decline from Alzheimer's disease and/or cerebrovascular origin have received the drug, in the first 4 weeks in 4800, later 2400 mg daily doses." | 6.69 | [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia]. ( Paksy, A; Tariska, P, 2000) |
| "Depression was evaluated in all experimental groups using the tail suspension and sucrose preference test on days 1, 5, 10 and 15, 2 h after pentylenetetrazole challenge." | 5.46 | Adjuvant quercetin therapy for combined treatment of epilepsy and comorbid depression. ( Goel, RK; Kaur, T; Singh, T, 2017) |
| "Thirty outpatients given systemic corticosteroid therapy for asthma were randomized to either levetiracetam (1500 mg/day) or placebo given concurrently with the corticosteroids." | 5.12 | Impact of levetiracetam on mood and cognition during prednisone therapy. ( Bret, ME; Brown, ES; Frol, AB; Khan, DA; Larkin, GL, 2007) |
| "Patients with cognitive decline from Alzheimer's disease and/or cerebrovascular origin have received the drug, in the first 4 weeks in 4800, later 2400 mg daily doses." | 2.69 | [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia]. ( Paksy, A; Tariska, P, 2000) |
| "Depression was evaluated in all experimental groups using the tail suspension and sucrose preference test on days 1, 5, 10 and 15, 2 h after pentylenetetrazole challenge." | 1.46 | Adjuvant quercetin therapy for combined treatment of epilepsy and comorbid depression. ( Goel, RK; Kaur, T; Singh, T, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taneja, R | 1 |
| Hunter, K | 1 |
| Burakgazi-Dalkilic, E | 1 |
| Carran, M | 1 |
| Medvedev, VE | 1 |
| Frolova, VI | 1 |
| Epifanov, AV | 1 |
| Singh, T | 1 |
| Kaur, T | 1 |
| Goel, RK | 1 |
| Yatham, LN | 1 |
| Brown, ES | 1 |
| Frol, AB | 1 |
| Khan, DA | 1 |
| Larkin, GL | 1 |
| Bret, ME | 1 |
| Mazza, M | 1 |
| Martini, A | 1 |
| Scoppetta, M | 1 |
| Mazza, S | 1 |
| Gertz, HJ | 1 |
| Kanowski, S | 1 |
| Gualtieri, CT | 1 |
| Golden, RN | 1 |
| Fahs, JJ | 1 |
| Tariska, P | 1 |
| Paksy, A | 1 |
| Otroshchenko, NP | 1 |
| Ezzat, DH | 1 |
| Ibraheem, MM | 1 |
| Makhawy, B | 1 |
2 reviews available for piracetam and Depression, Endogenous
| Article | Year |
|---|---|
Newer anticonvulsants in the treatment of bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Bipolar Disorder; Carbamazepine; Cyclohexanecarboxylic Acids; Dep | 2004 |
New developments in pediatric psychopharmacology.
Topics: Adolescent; Adult; Aggression; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Autistic Disorder | 1983 |
7 trials available for piracetam and Depression, Endogenous
| Article | Year |
|---|---|
[New possibilities of pharmacotherapy in cardiovascular patients with mental disorders].
Topics: Cardiovascular Diseases; Depressive Disorder; Female; gamma-Aminobutyric Acid; Humans; Male; Middle | 2014 |
Impact of levetiracetam on mood and cognition during prednisone therapy.
Topics: Adolescent; Adult; Affect; Aged; Anti-Inflammatory Agents; Antidepressive Agents; Asthma; Cognition; | 2007 |
Effect of levetiracetam on depression and anxiety in adult epileptic patients.
Topics: Adult; Age Factors; Anticonvulsants; Anxiety Disorders; Depressive Disorder; Dizziness; Epilepsies, | 2008 |
New developments in pediatric psychopharmacology.
Topics: Adolescent; Adult; Aggression; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Autistic Disorder | 1983 |
[Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition; Cognition Disorders; Dementia; Dementia, Vasc | 2000 |
[Psychopharmacotherapy in combine treatment of depressive disorders in patients with brain pathology affected by the Chernobyl Atomic Electric Power Station accident].
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Dothiepin; Drug Therapy, Combination; | 2000 |
The effect of Piracetam on ECT--induced memory disturbances.
Topics: Adolescent; Adult; Clinical Trials as Topic; Depressive Disorder; Electroconvulsive Therapy; Female; | 1985 |
3 other studies available for piracetam and Depression, Endogenous
| Article | Year |
|---|---|
Effect of sleep patterns on levetiracetam induced mood changes.
Topics: Adult; Analysis of Variance; Anticonvulsants; Anxiety Disorders; Circadian Rhythm; Depressive Disord | 2017 |
Adjuvant quercetin therapy for combined treatment of epilepsy and comorbid depression.
Topics: Animals; Anticonvulsants; Behavior, Animal; Brain; Combined Modality Therapy; Convulsants; Depressio | 2017 |
[Therapy of senile dementia of the Alzheimer type and multi-infarct dementia].
Topics: Alzheimer Disease; Animals; Brain; Cerebrovascular Circulation; Combined Modality Therapy; Dementia; | 1983 |